Post by
Georgealphabeta on Jan 14, 2012 2:34am
Strategic transactions
ISA in AUG/13 had debenture issued at 7% payable to 3SBio ( that might be converted to ISA shares at any point of of time at C
.155 by 3SBio). In 2009 ISA entered in to agreement with Palladin where Palladin acquired position bought at $.015 later sold to ILJIN @
.26. Recently ISA entered into agreement with VIFOR (the details of the agreement are being kept confidential), what is interesting that Peter Wijngaard of Vifor, is former director of Roche Pharma ( Roche cancelled agreement wit ISA in 2008) in charge of "global alliances) whatever that supposed to mean.LOL. And Vifor is an arm of Galenica, another powerhose pharma business based in Swiss just like Roche (by the way Novartis of Swiss owns 30% of Roche). So it seems that we have some interest in tiny ISA from people associated with pharma powerhouses that make ILJIN look like a dwarf. Now here it starts to be interesting, I understand that by Jan/28 ILJIN contractually should increase they positon in ISA, however the latest agreement beetwen VIFOR and ISA seems to muscled out ILJIN out of the picture, funny thing is that in the past ILJIN muscled Palladin out of the picture pretty much the same way. And the same way Palladin muscled itself in helpless ISA after Roche stopped financing ISA back in 2008. Here we come in to some stock technical analyses, basically trading patterns from past two weeks that seem to be identical or similiar to previous trading patterns from 2009- 2012 taken from periods preceding ISA alliances with Palladin and ILJIN. The thing is that latest release suggest that ILJIN considers fighting back. Since some magic financial forces put a cup on stock prices at
.15 or so and revelant informations are "confidential" I guess we will have to wait for few more weeks to see what will come out as a result of this brew, but it seems like big boys are here :-). Anyway this is all speculations and nothing might come out as a result:-).Cheers